These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Isocitrate dehydrogenase activity in liver and biliary tract diseases as an indicator of liver cell necrosis]. Trieb G; Nusser E Med Welt; 1971 Dec; 49():1951-6. PubMed ID: 5127502 [No Abstract] [Full Text] [Related]
3. [Enzymes in the diagnosis of liver diseases]. Lasala FG Prensa Med Argent; 1970 Mar; 57(3):129-32. PubMed ID: 5453820 [No Abstract] [Full Text] [Related]
4. [Diagnostic significance of serum isocitrate dehydrogenase in hepatobiliary diseases]. Hayashi S; Nishizaki T; Noma K; Kitada S Igaku To Seibutsugaku; 1971 May; 82(5):187-92. PubMed ID: 5165389 [No Abstract] [Full Text] [Related]
5. Glycylprolyl-p-nitroanilidase in hepatobiliary disease. Hutchinson DR; Halliwell RP; Lockhart JD; Parke DV Clin Chim Acta; 1981 Jan; 109(1):83-9. PubMed ID: 6110497 [TBL] [Abstract][Full Text] [Related]
6. [Determination of serum isocitrate dehydrogenase in patients with hepatobiliary diseases]. Cremer Nicolini G An Fac Med Lima; 1965 Jun; 48(2):297-317. PubMed ID: 5850391 [No Abstract] [Full Text] [Related]
7. [Quantitative determination of glutamate dehydrogenase (GLDH) and of isocitrate dehydrogenase (ISDH) in the blood during hepatopathies]. Spano G; Bragotti R; Caocci L; Dioguardi N Boll Soc Ital Biol Sper; 1967 Jul; 43(14):845-8. PubMed ID: 6056687 [No Abstract] [Full Text] [Related]
8. [Serum 5'nucleotidase activity in hepatobiliary diseases]. Cortés Rius M; Ferragút Canals A; Simón Lamuela MA; Gosalvez AM; Esque Bernadas C; Concustell Bas E Rev Clin Esp; 1975 Jul; 138(2):137-41. PubMed ID: 1178958 [No Abstract] [Full Text] [Related]
9. [Thermolabile fraction of LDH in diseases of the liver and of the biliary tract]. Kocián J; Englis M; Vanista J Cesk Gastroenterol Vyz; 1967 Apr; 21(3):148-9. PubMed ID: 6076702 [No Abstract] [Full Text] [Related]
10. [Urinary enzyme determinations in hepatobiliary diseases]. Burchardt U; Peters JE; Thulin H Z Gesamte Inn Med; 1973 Sep; 28(17):271-2 contd. PubMed ID: 4767184 [No Abstract] [Full Text] [Related]
11. The nature and origin of alkaline phosphatase in hepatobiliary disease. Moss DW Z Med Lab Diagn; 1989; 30(7):355-63. PubMed ID: 2690476 [No Abstract] [Full Text] [Related]
12. [Fractionated lactic acid dehydrogenase in liver and bile duct diseases]. Róin J; Simonsen EE; Hvidt S Ugeskr Laeger; 1970 Aug; 132(33):1509-11. PubMed ID: 5455861 [No Abstract] [Full Text] [Related]
13. In situ monitoring of caspase activation in hepatobiliary diseases. Bantel H; Ruck P; Schulze-Osthoff K Cell Death Differ; 2000 May; 7(5):504-5. PubMed ID: 10917736 [No Abstract] [Full Text] [Related]
14. Alkaline phosphatase in bile and urine. Excretion in patients with hepatobiliary disease. Allen H; Spellberg MA Arch Intern Med; 1967 Dec; 120(6):667-71. PubMed ID: 6058402 [No Abstract] [Full Text] [Related]
15. [Serum gamma-glutamyl transpeptidase: a sensitive indicator in hepatobiliary disorders]. Kammeraat C Ned Tijdschr Geneeskd; 1970 Oct; 114(44):1814-6. PubMed ID: 5471995 [No Abstract] [Full Text] [Related]
17. Lecithin: cholesterol acyltransferase levels in plasma of patients with hepatobiliary disease. Palacios Beristáin O; Vázquez I; Segovia Balmes E Arch Invest Med (Mex); 1984; 15(2):155-62. PubMed ID: 6487005 [No Abstract] [Full Text] [Related]
18. [Guanase and sorbit-dehydrogenase activity in patients with surgical pathology of the biliary tract]. Diachina EG Lab Delo; 1969; 5():281-4. PubMed ID: 4185257 [No Abstract] [Full Text] [Related]
19. [Study of several mediators and enzymes in diseases of the hepatobiliary system]. Barba EI; Vasiliuk VA; Kushnir VS Vrach Delo; 1976 Apr; (4):110-3. PubMed ID: 1007173 [No Abstract] [Full Text] [Related]